| Janssen Products, L.P. v. Ever Valinject GmbH, 24-9441 (N.D. Ill.) |
Oct. 3, 2024 |
Hon. Thomas M. Durkin |
Yondelis® (trabectedin injection) |
8,895,557
7,420,051 |
| American Regent, Inc. v. Accord Healthcare, Inc., 24-9600 (D.N.J.) |
Oct. 3, 2024 |
Hon. Brian R. Martinotti |
Tralement® (trace elements injection)
Multrys® (trace elements injection) |
11,786,548
11,975,022
11,998,565 |
| Galderma Labs., L.P. v. Macleods Pharms. Ltd., 24-1105 (D. Del.) |
Oct. 4, 2024 |
Hon. Stephanos Bibas |
Oracea® (doxycycline capsules) |
7,749,532
8,206,740 |
| Pfizer Inc. v. Breckenridge Pharm., Inc., 24-1122 (D. Del.) |
Oct. 9, 2024 |
Hon. Colm F. Connolly |
Xeljanz® (tofacitinib tablets) |
RE41,783 |
| Teva Branded Pharm. Products R&D, Inc. v. Cipla USA, Inc., 24-9691 (D.N.J.) |
Oct. 9, 2024 |
Hon. Stanley R. Chesler |
Qvar RediHaler® (beclomethasone dipropionate inhalation aerosol) |
8,132,712
8,931,476
10,022,509
10,022,510
10,086,156
10,561,808
10,695,512
10,792,447
11,395,888
11,395,889
11,559,637
11,583,643
11,793,953
11,865,247
11,896,759
11,957,832 |
| Novo Nordisk Inc. v. Apotex Inc., 24-9729 (D.N.J.) |
Oct. 10, 2024 |
Hon. Renee Marie Bumb |
Rybelsus® (semaglutide tablets) |
8,129,343
9,278,123
10,086,047
10,278,923
10,933,120
10,960,052
11,382,957
11,759,501
11,759,502
11,759,503 |
| Astellas Pharma Inc. v. Zydus Pharms. (USA) Inc., 24-9748 (D.N.J.) |
Oct. 11, 2024 |
Hon. Michael A. Shipp |
Xtandi® (enzalutamide tablets) |
11,839,689 |
| Advanced Accelerator Applications USA, Inc. v. Curium US LLC, 24-1161 (D. Del.) |
Oct. 17, 2024 |
Hon. Maryellen Noreika |
Lutathera® (lutetium Lu 177 dotatate injection) |
10,596,276
10,596,278
11,904,027 |
| Actelion Pharms. US, Inc. v. Lannett Co., Inc., 24-1162 (D. Del.) |
Oct. 17 |
Hon. Gregory B. Williams |
Uptravi® (selexipag tablets) |
8,791,122
9,284,280 |
| Advanced Accelerator Applications USA, Inc. v. Curium US LLC, 24-1392 (E.D. Mo.) |
Oct. 18, 2024 |
Hon. John M. Bodenhausen |
Lutathera® (lutetium Lu 177 dotatate injection) |
10,596,276
10,596,278
11,904,027 |
| Allergan Holdings Unlimited Co. v. MSN Labs. Private Ltd., 24-1187 (D. Del.) |
Oct. 23, 2024 |
Hon. Richard G. Andrews |
Viberzi® (eluxadoline tablets) |
12,097,187 |
| Allergan Holdings Unlimited Co. v. Sun Pharm. Indus. Ltd., 24-1188 (D. Del.) |
Oct. 23, 2024 |
Hon. Richard G. Andrews |
Viberzi® (eluxadoline tablets) |
12,097,187 |
| ViiV Healthcare Co. v. Hetero USA Inc., 24-1189 (D. Del.) |
Oct. 23, 2024 |
Hon. Mitchell S. Goldberg |
Tivicay® (dolutegravir tablets) |
9,242,986 |
| Sandoz Inc. v. Boehringer Ingelheim Pharms. Inc., 24-1192 (D. Del.) |
Oct. 24, 2024 |
Hon. Maryellen Noreika |
Ofev® (nintedanib capsules) |
9,907,756
10,105,323 |
| Novartis Pharms. Corp. v. MSN Pharms. Inc., 24-1193 (D. Del.) |
Oct. 24, 2024 |
Hon. Jennifer L. Hall |
Kisqali® (ribociclib tablets) |
8,962,630
9,416,136 |
| Cipla Ltd. v. Gilead Sciences, Inc., IPR2025-00033 (PTAB) |
Oct. 28, 2024 |
N/A |
Biktarvy® (bictegravir sodium / emtricitabine / tenofovir alafenamide fumarate tablets) |
11,744,802 |
| Exelixis, Inc. v. Sun Pharm. Indus. Ltd., 24-1208 (D. Del.) |
Oct. 30, 2024 |
Hon. Richard G. Andrews |
Cabometyx® (cabozantinib (S)-malate tablets) |
8,877,776
11,091,439
11,091,440
11,098,015 |
| Salix Pharms, Inc. v. Cipla USA, Inc., 24-10213 (D.N.J.) |
Nov. 1, 2024 |
Hon. Edward S. Kiel |
Xifaxan® (rifaximin tablets) |
11,564,912
11,779,571
8,193,196 |
| Intra-Cellular Therapies, Inc. v. Alkem Labs. Ltd., 24-10234 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Intra-Cellular Therapies, Inc. v. Aurobindo Pharma Ltd., 24-10235 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155 12,122,792 12,128,043 |
| Intra-Cellular Therapies, Inc. v. Dr. Reddy’s Labs. Inc., 24-10236 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Intra-Cellular Therapies, Inc. v. Hetero USA, Inc., 24-10237 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Intra-Cellular Therapies, Inc. v. MSN Labs. Private Ltd., 24-10238 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Intra-Cellular Therapies, Inc. v. Sandoz Inc., 24-10239 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Intra-Cellular Therapies, Inc. v. Zydus Pharms. (USA) Inc., 24-10240 (D.N.J.) |
Nov. 1, 2024 |
Hon. Michael A. Shipp |
Caplyta® (lumateperone capsules) |
12,090,155
12,122,792
12,128,043 |
| Salix Pharms, Inc. v. Carnegie Pharms. LLC, 24-10356 (D.N.J.) |
Nov. 7, 2024 |
Hon. Edward S. Kiel |
Xifaxan® (rifaximin tablets) |
11,564,912
11,779,571
8,193,196 |
| Pfizer Inc. v. Sandoz Inc., 24-1244 (D. Del.) |
Nov. 12, 2024 |
Hon Richard G. Andrews |
Inlyta® (axitinib tablets) |
8,791,140 |
| AstraZeneca Pharms. LP v. Zydus Pharms. (USA) Inc., 24-10458 (D.N.J.) |
Nov. 12, 2024 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
8,859,562
8,475,842
11,633,396
11,975,001
12,048,695 |
| AbbVie Inc. v. Hetero USA, Inc., 24-1254 (D. Del.) |
Nov. 14, 2024 |
Hon. Maryellen Noreika |
Rinvoq® (Upadacitinib tablets) |
12,077,545
12,103,933
12,110,297
12,116,373
12,110,298 |
| Genentech, Inc. v. Natco Pharma Ltd., 24-10567 (D.N.J.) |
Nov. 18, 2024 |
Hon. Brian R. Martinotti |
Evrysdi® (risdiplam oral solution) |
9,586,955
9,969,754
11,534,444
11,827,646
11,938,136 |
| Shionogi & Co., Ltd. v. Norwich Pharms., Inc., 24-1264 (D. Del.) |
Nov. 18, 2024 |
Hon. Maryellen Noreika |
Xofluza® (baloxavir marboxil tablets) |
12,064,438 |
| Azurity Pharms., Inc. v. Exelixis, Inc., IPR2025-00210 (PTAB) |
Nov. 18, 2024 |
N/A |
Cometriq® (cabozanitinib S-malate capsules) Cabometyx® (cabozanitinib S-malate tablets) |
11,298,349 |
| SK Biopharmaceuticals Co., Ltd. v. MSN Pharms. Inc., 24-1270 (D. Del.) |
Nov. 19, 2024 |
Hon. Jennifer L. Hall |
Xcopri® (cenobamate tablets) |
11,654,133 |
| Axsome Malta Ltd. v. Alkem Labs. Ltd., 24-10617 (D.N.J.) |
Nov. 20, 2024 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
12,090,126 |
| Axsome Malta Ltd. v. Hetero USA Inc., 24-10618 (D.N.J.) |
Nov. 20, 2024 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
12,090,126 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 24-10619 (D.N.J.) |
Nov. 20, 2024 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
12,090,126 |
| Axsome Malta Ltd. v. Hikma Pharms. USA Inc., 24-10620 (D.N.J.) |
Nov. 20, 2024 |
Hon. Madeline Cox Arleo |
Sunosi® (solriamfetol tablets) |
12,090,126
12,102,609 |
| AstraZeneca Pharms. LP v. Natco Pharma Ltd., 24-10624 (D.N.J.) |
Nov. 20, 2024 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
12,144,810 |
| AstraZeneca Pharms. LP v. Sandoz Inc., 24-10627 (D.N.J.) |
Nov. 20, 2024 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
12,144,810 |
| AstraZeneca Pharms. LP v. Cipla Ltd., 24-10628 (D.N.J.) |
Nov. 20, 2024 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
12,144,810 |
| AstraZeneca Pharms. LP v. Zydus Pharms. (USA) Inc., 24-10629 (D.N.J.) |
Nov. 20, 2024 |
Hon. Robert Kirsch |
Lynparza® (olaparib tablets) |
12,144,810 |
| American Regent, Inc. v. MSN Labs. Private Ltd., 24-10674 (D.N.J.) |
Nov. 22, 2024 |
Hon. Georgette Castner |
Injectafer® (ferric carboxymaltose injection) |
7,754,702 |
| Astellas Pharma Inc. v. Cipla Ltd., 24-1287 (D. Del.) |
Nov. 22, 2024 |
Hon. Gregory B. Williams |
Cresemba® (isavuconazonium sulfate injection) |
6,812,238 |
| Cassiopea S.p.A. v. Aurobindo Pharma Ltd., 24-10734 (D.N.J.) |
Nov. 25, 2024 |
Hon. Jamel K. Semper |
Winlevi® (clascoterone topical cream) |
8,785,427
9,433,628
9,486,458
10,159,682
11,207,332
11,938,141 |
| Eli Lilly & Co. v. Qilu Pharm. Co., Ltd., 24-10802 (D.N.J.) |
Nov. 27, 2024 |
Hon. Evelyn Padin |
Reyvow® (lasmiditan tablets) |
12,071,423 |
| Merck Sharp & Dohme LLC v. Zydus Pharms. (USA) Inc., 24-10820 (D.N.J.) |
Nov. 27, 2024 |
Hon. Karen M. Williams |
Prevymis® (letermovir tablets) |
RE 46,791 |
| Pacira Pharms., Inc. v. Fresenius Kabi USA, LLC, 24-12416 (N.D. Ill.) |
Dec. 3, 2024 |
Hon. Steven C. Seeger |
Exparel® (bupivacaine liposome injectable suspension) |
12,156,940 |
| Axsome Therapeutics, Inc. v. Teva Pharms., Inc., 24-10938 (D.N.J.) |
Dec. 5, 2024 |
Hon. Michael E. Farbiarz |
Auvelity® (dextromethorphan hydrobromide / bupropion HCl extended-release tablets) |
12,146,889 |
| Amicus Therapeutics US, LLC v. Aurobindo Pharma Ltd., 24-1331 (D. Del.) |
Dec. 6, 2024 |
Hon. Colm F. Connolly |
Galafold® (migalastat capsules) |
12,042,489
12,042,490
12,109,205 |
| Astellas Pharma Inc. v. Cipla Ltd., 24-1333 (D. Del.) |
Dec. 6, 2024 |
Hon. Gregory B. Williams |
Cresemba® (isavuconazonium sulfate capsules) |
6,812,238
10,206,879
10,603,280 |
| Vanda Pharms. Inc. v. Apotex Inc., 24-1344 (D. Del.) |
Dec. 9, 2024 |
Hon. Jennifer L. Hall |
Hetlioz® (tasimelteon capsules) |
11,918,556 |
| Vanda Pharms. Inc. v. Teva Pharms. USA, Inc., 24-1345 (D. Del.) |
Dec. 9, 2024 |
Hon. Jennifer L. Hall |
Hetlioz® (tasimelteon capsules) |
11,918,556 |
| eVenus Pharm. Labs., Inc. v. Pacira Pharms., Inc., 24-11014 (D.N.J.) |
Dec. 10, 2024 |
Hon. Madeline Cox Arleo |
Exparel® (bupivacaine liposome injectable suspension) |
12,156,940 |
| Aytu BioPharma, Inc. v. Granules Pharms. Inc., 24-1356 (D. Del.) |
Dec. 11, 2024 |
Hon. Colm F. Connolly |
Adzenys XR-ODT® (amphetamine extended-release orally disintegrating tablets) |
8,709,491
8,840,924
9,017,731
9,265,737 |
| Orbicular Pharm. Technologies Pvt. Ltd. v. Shire-NPS Pharms., Inc., 24-1366 (D. Del.) |
Dec. 13, 2024 |
Hon. Jennifer L. Hall |
Gattex® (teduglutide injection) |
7,847,061
9,060,992 |
| Novartis Pharms. Corp. v. Natco Pharma Ltd., 24-1367 (D. Del.) |
Dec. 13, 2024 |
Hon. Jennifer L. Hall |
Kisqali® (ribociclib tablets) |
9,868,739 |
| American Regent, Inc. v. Accord Healthcare Inc., 24-11108 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Aspiro Pharma Ltd., 24-11109 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Cipla USA, Inc., 24-11112 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Dr. Reddy’s Labs., Inc., 24-11114 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Gland Pharma Ltd., 24-11116 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Hikma Pharms. USA Inc., 24-11118 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. RK Pharma, Inc., 24-11122 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Somerset Therapeutics, LLC, 24-11124 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Sun Pharm. Indus. Ltd., 24-11126 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Xiromed, LLC, 24-11130 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Zydus Pharms. (USA) Inc., 24-11133 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
12,150,957 |
| American Regent, Inc. v. Somerset Therapeutics, LLC, 24-11138 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
11,998,565
12,150,957 |
| TherapeuticsMD, Inc. v. Teva Pharms. USA, Inc., 24-11161 (D.N.J.) |
Dec. 13, 2024 |
Hon. Brian R. Martinotti |
Imvexxy® (estradiol vaginal inserts) |
11,065,197
11,116,717
11,123,283
11,241,445
11,246,875
11,266,661
11,304,959
11,351,182
11,497,709 |
| Bausch Health Ireland Ltd. v. MSN Labs. Private Ltd., 24-11179 (D.N.J.) |
Dec. 16, 2024 |
Hon. Stanley R. Chesler |
Trulance® (plecanatide tablets) |
12,146,003 |
| Avadel CNS Pharms., LLC v. Jazz Pharms., Inc., 24-1384 (D. Del.) |
Dec. 17, 2024 |
Hon. Gregory B. Williams |
Lumryz® (sodium oxybate extended-release oral suspension) |
12,167,991 |
| Novartis Pharms. Corp. v. Umedica Labs. Pvt. Ltd., 24-1408 (D. Del.) |
Dec. 23, 2024 |
Hon. Richard G. Andrews |
Entresto® (sacubitril / valsartan tablets) |
8,101,659
8,877,938
9,388,134
9,517,226
9,937,143
11,058,667
11,096,918
11,135,192 |
| UCB, Inc. v. Aurobindo Pharma Ltd., 24-11428 (D.N.J.) |
Dec. 23, 2024 |
Hon. Claire C. Cecchi |
Neupro® (rotigotine transdermal system) |
8,246,979
9,925,150
10,130,589
10,350,174 |
| Athena Bioscience, LLC v. Novitium Pharma LLC, 24-1421 (D. Del.) |
Dec. 27, 2024 |
Hon. Gregory B. Williams |
Qdolo® (tramadol HCl oral solution) |
11,103,452
11,752,103 |
| Mitsubishi Tanabe Pharma Corp. v. Lupin Ltd., 24-1423 (D. Del.) |
Dec. 30, 2024 |
Hon. Jennifer L. Hall |
Radicava ORS® (edaravone oral suspension) |
10,987,341
11,241,416
11,478,450
11,826,352
11,957,660 |
| Pfizer Inc. v. Alkem Labs. Ltd., 24-1427 (D. Del.) |
Dec. 30, 2024 |
Hon. Colm F. Connolly |
Xeljanz® (tofacitinib tablets) |
RE41,783 |
| American Regent, Inc. v. Amneal Pharms. of NY, LLC, 24-11503 (D.N.J.) |
Dec. 30, 2024 |
Hon. Brian R. Martinotti |
Selenious Acid |
11,998,565
12,150,957 |
| Endo USA, Inc. v. Gland Pharma Ltd., 24-11529 (D.N.J.) |
Dec. 31, 2024 |
Hon. Zahid N. Quraishi |
Vasostrict® (vasopressin injection) |
9,919,026
9,925,233
9,925,234
9,962,422
9,968,649
9,974,827
9,981,006
10,010,575 |
